drugset / Trial / NCT04784533
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to evaluate the regrowth of hair with CTP-543 and subsequent durability of that regrowth following dose reduction in adult patients with moderate to severe alopecia areata.
Timeline
- Start
- 2021-02-26
- Primary completion
- 2023-05-16
- Completion
- 2023-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | 4 mg | Oral |
| Subject | CTP-543 | Unknown | 8 mg | Oral |
| Subject | CTP-543 | Unknown | 12 mg | Oral |